Ventas (VTR) VTR quarter Financial Results Summary
QuoteReporter
Ventas, Inc. (VTR) Q4 2025 Financial Results Summary
Release Date: February 5, 2026
Ventas, Inc. reported strong financial results for the fourth quarter and full year ended December 31, 2025. Below is a summary of key metrics and highlights from the report.
Fourth Quarter 2025 Financial Highlights
- Net Income Attributable to Common Stockholders:
- Q4 2025: $0.15 per share
- Q4 2024: $0.13 per share
-
Change: +15% year-over-year
-
Nareit Funds From Operations (FFO):
- Q4 2025: $0.91 per share
- Q4 2024: $0.85 per share
-
Change: +7% year-over-year
-
Normalized Funds From Operations:
- Q4 2025: $0.89 per share
- Q4 2024: $0.81 per share
-
Change: +10% year-over-year
-
Total Company Net Operating Income (NOI):
- Year-over-year growth: 15%
-
Same-Store Cash NOI: 8% growth year-over-year
-
Senior Housing Operating Portfolio (SHOP) Performance:
- Same-Store Cash NOI growth: over 15%
- Average occupancy growth: 300 basis points year-over-year
- U.S. portfolio growth: 18%
Full Year 2025 Financial Highlights
- Net Income Attributable to Common Stockholders:
- Full Year 2025: $0.54 per share
- Full Year 2024: $0.19 per share
-
Change: +184% year-over-year
-
Nareit FFO:
- Full Year 2025: $3.50 per share
- Full Year 2024: $3.14 per share
-
Change: +11% year-over-year
-
Normalized FFO:
- Full Year 2025: $3.48 per share
- Full Year 2024: $3.19 per share
-
Change: +9% year-over-year
-
Total Company NOI Growth:
- Year-over-year growth: 16%
-
Same-Store Cash NOI growth: 8%
-
Senior Housing Investments:
- Closed $2.5 billion in investments for the year 2025.
Shareholder Returns and Financial Health
- Quarterly Dividend Declared:
- $0.52 per common share, which is an 8% increase from previous dividends.
-
Expected payment date: April 16, 2026, for stockholders of record on March 31, 2026.
-
Financial Flexibility:
- As of December 31, 2025, Ventas maintained $5.3 billion in liquidity to support growth and investments.
- Net Debt-to-Further Adjusted EBITDA improved to 5.2x.
Outlook for 2026
- Attributable Net Income Guidance (2026):
-
Expected range: $0.52 – $0.62 per share
-
Nareit FFO Guidance (2026):
-
Expected range: $3.63 – $3.73 per share
-
Normalized FFO Guidance (2026):
-
Expected range: $3.78 – $3.88 per share
-
Projected Growth:
- Midpoint guidance reflects a 6% increase on Attributable Net Income compared to 2025 and an 8% increase on Normalized FFO.
Key Takeaways
- Strong Growth: Ventas achieved significant year-over-year growth across multiple financial metrics, highlighting effective management strategies and market positioning.
- Continued Investment: The company closed substantial investments in senior housing and anticipates continued demand, benefiting from aging population trends.
- Increased Shareholder Returns: The notable increase in dividends reflects the company’s strong financial performance and a positive outlook.
For more detailed information on Ventas’s performance, refer to the Earnings Presentation available on their investor relations website.
Here are the extracted tables from the press release:
CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts; dollars in USD; unaudited)
| Revenues | For the Three Months Ended December 31, | ||||
|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | ||
| Triple-net leased properties | $132,713 | $157,403 | $601,578 | $622,054 | |
| Outpatient medical and research portfolio | $226,756 | $216,199 | $895,089 | $874,886 | |
| $359,469 | $373,602 | $1,496,667 | $1,496,940 | ||
| Resident fees and services | $1,185,999 | $896,360 | $4,276,163 | $3,372,796 | |
| Third-party capital management revenues | $4,322 | $4,339 | $17,547 | $17,359 | |
| Income from loans and investments | $8,350 | $4,451 | $22,593 | $9,057 | |
| Interest and other income | $7,877 | $8,305 | $21,010 | $28,114 | |
| Total revenues | $1,566,017 | $1,287,057 | $5,833,980 | $4,924,266 | |
| Expenses | |||||
| Interest | $154,468 | $153,206 | $612,246 | $602,835 | |
| Depreciation and amortization | $352,723 | $308,772 | $1,379,140 | $1,253,143 | |
| Property-level operating expenses: | |||||
| Senior housing | $855,147 | $661,683 | $3,092,099 | $2,506,413 | |
| Outpatient medical and research portfolio | $77,639 | $73,617 | $307,733 | $298,320 | |
| $935,786 | $739,506 | $3,413,337 | $2,820,562 | ||
| Third-party capital management expenses | $1,610 | $1,551 | $6,579 | $6,507 | |
| General, administrative and professional fees | $41,008 | $41,434 | $177,400 | $162,990 | |
| Loss on extinguishment of debt, net | $53 | $15 | $172 | $687 | |
| Transaction, transition and restructuring costs | -$6,008 | $4,226 | $10,073 | $20,369 | |
| Reversal of allowance on loans receivable and investments, net | — | — | — | -$166 | |
| Shareholder relations matters | — | — | — | $15,751 | |
| Other expense | $10,091 | $38,855 | $30,712 | $49,584 | |
| Total expenses | $1,489,731 | $1,287,565 | $5,629,659 | $4,932,262 | |
| Income (loss) before unconsolidated entities, real estate dispositions, income taxes and noncontrolling interests | $76,286 | -$508 | $204,321 | -$7,996 | |
| (Loss) income from unconsolidated entities | -$7,727 | $6,969 | $4,468 | $1,563 | |
| Gain on real estate dispositions | $3,311 | $6,727 | $38,579 | $57,009 | |
| Income tax benefit | $1,122 | $45,539 | $14,150 | $37,775 | |
| Net income | $72,992 | $58,727 | $261,518 | $88,351 | |
| Net income attributable to noncontrolling interests | $2,790 | $1,892 | $10,137 | $7,198 | |
| Net income attributable to common stockholders | $70,202 | $56,835 | $251,381 | $81,153 | |
| Earnings per common share | |||||
| Basic: | $0.15 | $0.14 | $0.57 | $0.21 | |
| Net income attributable to common stockholders | $0.15 | $0.13 | $0.55 | $0.20 | |
| Diluted: | $0.15 | $0.14 | $0.57 | $0.21 | |
| Net income attributable to common stockholders | $0.15 | $0.13 | $0.54 | $0.19 | |
| Weighted average shares used in computing earnings per common share | Basic | 471,138 | 421,496 | 455,082 | 411,770 |
| Diluted | 480,763 | 427,612 | 462,615 | 416,366 |
CONSOLIDATED BALANCE SHEETS
(In thousands, except per share amounts; dollars in USD; unaudited)
| Assets | As of December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Real estate investments: | ||
| Land and improvements | $2,962,738 | $2,775,790 |
| Buildings and improvements | $30,872,598 | $28,717,990 |
| Construction in progress | $358,811 | $336,231 |
| Acquired lease intangibles | $1,680,567 | $1,558,751 |
| Operating lease assets | $295,838 | $308,019 |
| Total | $36,170,552 | $33,696,781 |
| Accumulated depreciation and amortization | -$12,043,619 | -$11,096,236 |
| Net real estate property | $24,126,933 | $22,600,545 |
| Secured loans receivable and investments, net | $143,913 | $144,872 |
| Investments in unconsolidated real estate entities | $617,571 | $626,122 |
| Net real estate investments | $24,888,417 | $23,371,539 |
| Cash and cash equivalents | $741,067 | $897,850 |
| Escrow deposits and restricted cash | $45,070 | $59,383 |
| Goodwill | $1,046,072 | $1,044,915 |
| Assets held for sale | $42,993 | $18,625 |
| Deferred income tax assets, net | $2,797 | $1,931 |
| Other assets | $825,529 | $792,663 |
| Total assets | $27,591,945 | $26,186,906 |
| Liabilities and equity | ||
| Liabilities: | ||
| Senior notes payable and other debt | $13,011,016 | $13,522,551 |